AcelRx Pharmaceuticals In... (ACRX)
NASDAQ: ACRX
· Real-Time Price · USD
0.86
0.06 (7.50%)
At close: Jan 09, 2024, 9:00 PM
7.50% (1D)
| Bid | n/a |
| Market Cap | 14.58M |
| Revenue (ttm) | 622K |
| Net Income (ttm) | -7.88M |
| EPS (ttm) | -2.75 |
| PE Ratio (ttm) | -0.31272727272727274 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 240,995 |
| Avg. Volume (20D) | 138,824 |
| Open | 0.78 |
| Previous Close | 0.80 |
| Day's Range | 0.78 - 0.88 |
| 52-Week Range | 0.42 - 2.30 |
| Beta | 0.52 |
About ACRX
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai...
Sector Healthcare
IPO Date Feb 11, 2011
Employees 19
Stock Exchange NASDAQ
Ticker Symbol ACRX
Website https://www.acelrx.com